Related Experiment Video
Updated: Jun 4, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Chemical, In Cellulo, and In Silico Characterization of the Aminocholine Analogs of VG
Stavroula Kostoudi1,2, Nikolaos Iatridis2, Dimitra Hadjipavlou-Litina1
1Laboratory of Pharmaceutical Chemistry, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
New V-agent analogs, phosphorylated aminocholines, were synthesized but failed to inhibit acetylcholinesterase (AChE). One compound, P4, unexpectedly increased AChE activity, offering potential for safer nerve agent countermeasures and pretreatments.
Area of Science:
- Medicinal Chemistry
- Neuroscience
- Toxicology
Background:
- V-type nerve agents are highly toxic chemical warfare agents that inhibit acetylcholinesterase (AChE), disrupting neurotransmission.
- Previous research synthesized various V-agent analogs, but aminocholine derivatives remained unexplored.
Purpose of the Study:
- To design and synthesize novel phosphorylated aminocholines as VG analogs.
- To evaluate their potential as acetylcholinesterase (AChE) inhibitors and nerve agent mimics.
Main Methods:
- Synthesis of phosphorylated aminocholines.
- Characterization using NMR spectroscopy (1H, 13C, 31P, TOCSY).
- In silico analysis of pharmacological properties and in vitro toxicological investigation using SH-SY5Y cells.
Main Results:
- Synthesized compounds exhibited drug-likeness but failed to inhibit AChE in vitro and in cellulo.
- The aminocholine moiety was identified as a poor leaving group compared to thiocholine.
- Compound P4 uniquely demonstrated an increase in AChE activity.
Conclusions:
- The novel aminocholine analogs are not effective AChE inhibitors.
- These compounds could serve as safer nerve agent mimics for developing countermeasures.
- P4 shows promise as a lead for developing safer nerve agent pretreatment strategies.
More Related Videos
10:04Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
Published on: October 29, 2012
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
Related Concept Videos
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...